Axogen Statistics

Total Valuation

Axogen has a market cap or net worth of GBP 364.53 million. The enterprise value is 400.36 million.

Market Cap	364.53M
Enterprise Value	400.36M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	45.54M
Shares Outstanding	n/a
Shares Change (YoY)	+3.96%
Shares Change (QoQ)	-5.95%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	44.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	38.09
PS Ratio	2.42
PB Ratio	4.47
P/TBV Ratio	4.73
P/FCF Ratio	396.11
P/OCF Ratio	130.03
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 49.56, with an EV/FCF ratio of 435.04.

EV / Earnings	-72.21
EV / Sales	2.81
EV / EBITDA	49.56
EV / EBIT	n/a
EV / FCF	435.04

Financial Position

The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.67.

Current Ratio	4.28
Quick Ratio	2.22
Debt / Equity	0.67
Debt / EBITDA	6.44
Debt / FCF	59.71
Interest Coverage	-0.05

Financial Efficiency

Return on equity (ROE) is -7.22% and return on invested capital (ROIC) is -0.14%.

Return on Equity (ROE)	-7.22%
Return on Assets (ROA)	-0.13%
Return on Invested Capital (ROIC)	-0.14%
Return on Capital Employed (ROCE)	-0.22%
Revenue Per Employee	333,090
Profits Per Employee	-12,266
Employee Count	452
Asset Turnover	1.02
Inventory Turnover	1.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.78% in the last 52 weeks. The beta is 0.76, so Axogen's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+38.78%
50-Day Moving Average	12.16
200-Day Moving Average	14.90
Relative Strength Index (RSI)	51.57
Average Volume (20 Days)	304

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.69

Income Statement

In the last 12 months, Axogen had revenue of GBP 150.56 million and -5.54 million in losses. Loss per share was -0.12.

Revenue	150.56M
Gross Profit	111.68M
Operating Income	-300,308
Pretax Income	-5.54M
Net Income	-5.54M
EBITDA	5.08M
EBIT	-300,308
Loss Per Share	-0.12

Full Income Statement

Balance Sheet

The company has 17.08 million in cash and 54.95 million in debt, giving a net cash position of -37.87 million.

Cash & Cash Equivalents	17.08M
Total Debt	54.95M
Net Cash	-37.87M
Net Cash Per Share	n/a
Equity (Book Value)	81.55M
Book Value Per Share	1.79
Working Capital	55.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.80 million and capital expenditures -1.88 million, giving a free cash flow of 920,274.

Operating Cash Flow	2.80M
Capital Expenditures	-1.88M
Free Cash Flow	920,274
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.18%, with operating and profit margins of -0.20% and -3.68%.

Gross Margin	74.18%
Operating Margin	-0.20%
Pretax Margin	-3.68%
Profit Margin	-3.68%
EBITDA Margin	3.37%
EBIT Margin	-0.20%
FCF Margin	0.61%

Dividends & Yields

Axogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.96%
Shareholder Yield	n/a
Earnings Yield	-1.52%
FCF Yield	0.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Axogen has an Altman Z-Score of 2.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.93
Piotroski F-Score	4